Use Natural Alternatives International Inc. historical price analysis together with your assets to enhance returns of your portfolios as well as to check it against diversification policy that fits your risk preferences.
The price series of Natural for the period between Thu, Apr 26, 2012 and Sat, May 26, 2012 has a statistical range of 0.91 with a coefficient of variation of 5.61. The daily prices for the period are spread out with arithmetic mean of 7.0. The median price for the last 30 days is 6.76
Date
Open
High
Low
Close
Volume
05/25/2012
7.48
7.48
7.48
7.48
1,100
05/24/2012
7.46
7.46
7.46
7.46
1.00
05/23/2012
7.38
7.49
7.34
7.46
6,400
05/22/2012
7.51
7.57
7.34
7.43
16,000
05/21/2012
7.58
7.58
7.25
7.45
20,600
05/18/2012
7.45
7.50
7.09
7.21
9,800
05/17/2012
7.54
7.55
6.98
7.06
25,200
05/16/2012
7.52
7.69
7.26
7.50
20,200
05/15/2012
7.02
8.34
7.02
7.50
44,000
05/14/2012
6.93
6.93
6.65
6.76
25,800
05/11/2012
6.66
6.80
6.66
6.73
5,200
05/10/2012
6.67
6.67
6.58
6.65
1,200
05/09/2012
6.63
6.67
6.55
6.66
2,500
05/08/2012
6.67
6.68
6.57
6.63
900
05/07/2012
6.67
6.67
6.59
6.65
1,800
05/04/2012
6.68
6.69
6.58
6.60
24,400
05/03/2012
6.65
6.68
6.54
6.68
3,500
05/02/2012
6.64
6.68
6.54
6.68
4,400
05/01/2012
6.67
6.69
6.56
6.65
7,800
04/30/2012
6.59
6.69
6.55
6.63
14,000
04/27/2012
6.25
6.60
6.05
6.59
37,900
04/26/2012
6.20
6.34
6.18
6.29
6,600
Discuss Natural historical price analysis
Natural Market Capitalization
Natural Alternatives International Inc. is rated below average in market capitalization category among related companies. Market capitalization of Drug Related Products industry is now estimated at about 17.69 Billion. Natural adds roughly 52.12 Million in market capitalization claiming only tiny portion of equities under Drug Related Products industry.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
